Literature DB >> 29908816

Structural basis of pyrrole polymerization in human porphobilinogen deaminase.

Paula Pluta1, Pietro Roversi2, Ganeko Bernardo-Seisdedos1, Adriana L Rojas3, Jonathan B Cooper4, Shuang Gu5, Richard W Pickersgill5, Oscar Millet6.   

Abstract

Human porphobilinogen deaminase (PBGD), the third enzyme in the heme pathway, catalyzes four times a single reaction to convert porphobilinogen into hydroxymethylbilane. Remarkably, PBGD employs a single active site during the process, with a distinct yet chemically equivalent bond formed each time. The four intermediate complexes of the enzyme have been biochemically validated and they can be isolated but they have never been structurally characterized other than the apo- and holo-enzyme bound to the cofactor. We present crystal structures for two human PBGD intermediates: PBGD loaded with the cofactor and with the reaction intermediate containing two additional substrate pyrrole rings. These results, combined with SAXS and NMR experiments, allow us to propose a mechanism for the reaction progression that requires less structural rearrangements than previously suggested: the enzyme slides a flexible loop over the growing-product active site cavity. The structures and the mechanism proposed for this essential reaction explain how a set of missense mutations result in acute intermittent porphyria.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute intermittent porphyria; Enzyme mechanism; Heme biosynthesis; Human porphobilinogen deaminase (PBGD); Reaction intermediates; X-ray structure

Mesh:

Substances:

Year:  2018        PMID: 29908816      PMCID: PMC6192514          DOI: 10.1016/j.bbagen.2018.06.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  39 in total

Review 1.  Tetrapyrroles: the pigments of life.

Authors:  A R Battersby
Journal:  Nat Prod Rep       Date:  2000-12       Impact factor: 13.423

2.  Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing.

Authors:  D I Svergun
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

Review 3.  Small-angle scattering: a view on the properties, structures and structural changes of biological macromolecules in solution.

Authors:  Michel H Koch; Patrice Vachette; Dmitri I Svergun
Journal:  Q Rev Biophys       Date:  2003-05       Impact factor: 5.318

4.  Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals.

Authors:  Katherine A Kantardjieff; Bernhard Rupp
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

5.  Structure of porphobilinogen deaminase reveals a flexible multidomain polymerase with a single catalytic site.

Authors:  G V Louie; P D Brownlie; R Lambert; J B Cooper; T L Blundell; S P Wood; M J Warren; S C Woodcock; P M Jordan
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

6.  Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT.

Authors:  E Blanc; P Roversi; C Vonrhein; C Flensburg; S M Lea; G Bricogne
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

7.  Mutagenesis of arginine residues in the catalytic cleft of Escherichia coli porphobilinogen deaminase that affects dipyrromethane cofactor assembly and tetrapyrrole chain initiation and elongation.

Authors:  P M Jordan; S C Woodcock
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

8.  Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability.

Authors:  Arola Fortian; David Castaño; Gabriel Ortega; Ana Laín; Miquel Pons; Oscar Millet
Journal:  Biochemistry       Date:  2009-01-20       Impact factor: 3.162

9.  Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria.

Authors:  Raj Gill; Simon E Kolstoe; Fiyaz Mohammed; Abeer Al D-Bass; Julie E Mosely; Mohammed Sarwar; Jonathan B Cooper; Stephen P Wood; Peter M Shoolingin-Jordan
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

10.  Structural insight into acute intermittent porphyria.

Authors:  Gaojie Song; Yang Li; Chongyun Cheng; Yu Zhao; Ang Gao; Rongguang Zhang; Andrzej Joachimiak; Neil Shaw; Zhi-Jie Liu
Journal:  FASEB J       Date:  2008-10-20       Impact factor: 5.191

View more
  5 in total

1.  Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria.

Authors:  Yibao Fu; Jinmeng Jia; Lishu Yue; Ruiying Yang; Yongli Guo; Xin Ni; Tieliu Shi
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

2.  A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria.

Authors:  Helene J Bustad; Karen Toska; Caroline Schmitt; Marta Vorland; Lars Skjærven; Juha P Kallio; Sylvie Simonin; Philippe Letteron; Jarl Underhaug; Sverre Sandberg; Aurora Martinez
Journal:  Mol Ther       Date:  2019-12-04       Impact factor: 11.454

Review 3.  Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.

Authors:  Helene J Bustad; Juha P Kallio; Marta Vorland; Valeria Fiorentino; Sverre Sandberg; Caroline Schmitt; Aasne K Aarsand; Aurora Martinez
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

4.  Characterization of porphobilinogen deaminase mutants reveals that arginine-173 is crucial for polypyrrole elongation mechanism.

Authors:  Helene J Bustad; Juha P Kallio; Mikko Laitaoja; Karen Toska; Inari Kursula; Aurora Martinez; Janne Jänis
Journal:  iScience       Date:  2021-02-06

5.  Two Novel Hydroxymethylbilane Synthase Splicing Mutations Predispose to Acute Intermittent Porphyria.

Authors:  Yanping Zhang; Han Xiao; Qiuhong Xiong; Changxin Wu; Ping Li
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.